Metraipolis › archive › dc_7313e2ed1d7f

Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma — Europe PMC PMID:40943426

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40943426
DOI
10.3390/ijms26178505
License (as archived)
solo-consultazione
Archived
2026-11-10T04:56:45.922Z
SHA-256 of the archived text
f152f5ee0f7c7aa065c5ea0db3187a7f6b9df7f5fde976a94b492f1975bb39e1
Stable URL of this page
https://metraipolis.com/documento/dc_7313e2ed1d7f

How to cite

Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma — Europe PMC PMID:40943426 — Europe PMC (en), https://europepmc.org/article/MED/40943426 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7313e2ed1d7f (Metraipolis archive dc_7313e2ed1d7f, sha256 f152f5ee0f7c7aa065c5ea0db3187a7f6b9df7f5fde976a94b492f1975bb39e1)
BibTeX
@misc{dc7313e2ed1d7f,
  title = {Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma — Europe PMC PMID:40943426},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40943426},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7313e2ed1d7f; sha256 f152f5ee0f7c7aa065c5ea0db3187a7f6b9df7f5fde976a94b492f1975bb39e1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40943426. Agents can read the archived copy with the MCP tool read_document.